Unlocking Success with Phoenix® Cloud: リアルワールドのお客様のストーリー

A small biopharmaceutical company relies on Phoenix NLME for advanced modeling and simulation. They appreciate the virtualized desktop managed by Certara, ensuring high performance and stability, as well as the convenience of remote job execution. After a two-week evaluation, they transitioned to full production in just four weeks and have been successfully using Phoenix Cloud for over a year.

A Tier 2 biopharmaceutical company with five users needed a secure, controlled environment for NCA analysis and regulatory reporting. With Certara handling hosting, installation, security, and version control, they streamlined workflows and ensured compliance. The integration of PKSubmit enabled high-throughput NCA analyses with CDISC-compliant outputs. Their system went live in June 2024, delivering efficiency and compliance.

A mid-sized pharmaceutical company in the US deployed Phoenix Cloud across preclinical PK and ClinPharm GxP studies for 12 users. Key benefits included technical controls, compliance-ready data management, and system validation by Certara. Their journey—from evaluation in May to full production in January—demonstrates Phoenix Cloud ’s scalability. They later expanded their system with NLME licenses and 14 active users.